From ignoring Medicare concentration risk to skipping billing audits, these errors cost buyers hundreds of thousands. Here's how to acquire a podiatry practice without blowing the deal.
Find Vetted Podiatry Practice DealsPodiatry practice acquisitions carry unique risks that generic business buyers routinely underestimate. Between physician-dependent revenue, Medicare reimbursement exposure, and corporate practice of medicine restrictions, the margin for diligence error is thin. This guide exposes the six most damaging mistakes buyers make.
When the selling podiatrist generates 90%+ of collections personally, the business leaves with them. Buyers frequently overpay for goodwill that dissolves the moment the seller reduces clinical hours.
How to avoid: Require at least one associate podiatrist generating measurable independent revenue. Structure earnouts tied to 12–24 month post-close patient retention and collections performance before paying full price.
A payer mix exceeding 70% government payors creates dangerous reimbursement exposure. Medicare routine foot care and diabetic billing codes face recurring CMS rate reductions that directly compress practice EBITDA.
How to avoid: Analyze the trailing 24-month payer mix by collections percentage. Target practices with Medicare under 60% and meaningful commercial insurance revenue from orthopedic, wound care, and surgical procedures.
Upcoded E&M visits, improper orthotics billing, and undocumented diabetic care claims are common in podiatry. Buyers inherit Medicare overpayment liability and OIG audit exposure if compliance isn't verified pre-close.
How to avoid: Engage a healthcare billing compliance consultant to audit 90–180 days of claims before closing. Verify denial rates, coding accuracy for CPT codes 99211–99215, and any open insurance disputes.
Podiatry practice P&Ls frequently commingle personal vehicle leases, family payroll, and discretionary travel. Buyers accepting inflated EBITDA without normalizing owner expenses systematically overpay at 3–5.5x multiples.
How to avoid: Reconstruct SDE using three years of tax returns and bank statements. Apply market-rate physician compensation of $180K–$220K annually before calculating true EBITDA for valuation purposes.
Non-physician buyers and DSO platforms often overlook state-specific CPOM restrictions. Some states prohibit lay entities from owning or directing podiatry practices, invalidating deal structures post-close.
How to avoid: Engage a healthcare M&A attorney pre-LOI to assess CPOM restrictions in the target state. Structure the transaction using a compliant MSO model or physician-owned PC before committing to deal terms.
Podiatry referrals from PCPs, endocrinologists, and orthopedic surgeons are often personal relationships with the selling physician. Buyers assuming practice-level referral networks exist without verification face immediate revenue decline.
How to avoid: Request referral source documentation, including written agreements or documented outreach histories. During diligence, assess whether referrals flow to the practice brand or directly to the selling physician personally.
Podiatry practices typically trade at 3x–5.5x EBITDA. Practices with associate podiatrists, diversified payer mix, and documented systems command the upper range. Single-physician, Medicare-heavy practices warrant lower multiples.
It depends on state law. Many states have corporate practice of medicine restrictions requiring physician ownership. Non-physician buyers typically use a management services organization structure with a licensed podiatrist as nominal owner.
Structure a 12–24 month employment agreement with a compensation package at market rate plus earnout tied to patient retention. Align incentives so the seller benefits financially from a successful transition to new ownership.
Yes. SBA 7(a) loans are commonly used, typically requiring 10–15% buyer equity injection. Lenders will scrutinize payer mix stability, physician transition risk, and practice cash flow coverage of debt service before approval.
More Podiatry Practice Guides
DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers